VCG
LMAT icon

Vantage Consulting Group’s LeMaitre Vascular LMAT Stock Holding History

Vantage Consulting Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-359
Closed -$15K – 905
2020
Q4 		$15K Buy
+359
New +$12.8K ﹤0.01% 1015

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Vantage Consulting Group's LMAT Position: Q1 2021 in Review

Vantage Consulting Group sold out of LeMaitre Vascular (LMAT) in Q1 2021, closing a stake of 359 shares — an estimated $15K sold.

Vantage Consulting Group first reported a position in LMAT in Q4 2020 and held it in 1 quarter. The position peaked at $15K in Q4 2020. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.

  • Vantage Consulting Group reported no remaining LeMaitre Vascular position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 359 LeMaitre Vascular shares in Q1 2021, an estimated $15K.
  • Vantage Consulting Group first reported a position in LeMaitre Vascular in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's LeMaitre Vascular position peaked at $15K in Q4 2020.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.